The Shufeng Jiedu capsule produced by Anhui Jiren Pharmaceutical Co., Ltd., as a therapeutic drug for acute respiratory infections, was awarded by the Chinese Society of Traditional Chinese Medicine and the Alliance of Chinese Medicines: the first place in the field of respiratory diseases and the fourth place in the non-injection category , The sixth place in all categories in the country, the first place in Anhui Province.
The use value of drugs comes from clinical application, and clinical value is the core basis of drugs, and it is also the basis for determining their market value and social value. The scientific and technological competitiveness embodies the clinical value and scientific value of Chinese medicine, and will become the core competitiveness of Chinese medicine products in the future. In order to demonstrate the scientific and technological competitiveness of superior Chinese medicine products, promote the cooperation of various innovative entities, and promote the transformation of scientific and technological achievements in Chinese medicine, the Chinese Society of Chinese Medicine held the "Fourth Forum of Chinese Medicines and Chinese Medicines" on December 25-26, 2018 in Beijing. Release Conference of the Report on the Competitiveness of Large-scale Science and Technology The report selects 569 major Chinese medicine varieties with "high clinical value, strong scientific value, and high market value" from nearly 60,000 proprietary Chinese medicine products. based on the industry consensus evaluation model, and based on public data, it is objectively evaluated. Demonstrate the technological competitiveness of large varieties of traditional Chinese medicine.